RE: Downside Peril? This is a jokeThe story of Bioniche is not getting out and I'm not sure why.
Maybe the story IS getting out?
The repeated story of endless delays and missed deadlines, the constant under delivering, financings, incompetence, what will the FDA do and when will they do it, cash burn, totally sold out on Urocidin partnership,....(feel free to add)
Until the company can repeatedly deliver (and BIGTIME), their credibilty is right where it should be - ZERO.
Which is where the share price is headed.